AddLife (OTC:ADDLF) Stock, Quote.Headers.trade-ideas

AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech segments. The Labtech segment, which accounts for the majority of the company revenue, provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service. The Medtech segment includes products related to surgery, thoracic medicine, neurology, wound care, anesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare. AddLife mainly caters to hospitals & laboratories within healthcare, research, colleges, and universities, as well as the food and pharmaceutical industries. Its geographical segments are Sweden, Denmark, Finland, Norway, and Other countries.

AddLife AB

Piper Sandler analyst Ryan Todd maintains Darling Ingredients (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) with a Overweight and lowers the price target from $50 to $48.

News

Price Target

Analyst Ratings

Piper Sandler Maintains Overweight on Darling Ingredients, Lowers Price Target to $48

CBLL

Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

JP Morgan analyst Chris Schott maintains IDEXX Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDXX#NASDAQ">IDXX</a>) with a Overweight and lowers the price target from $630 to $575.

IDXX

JP Morgan Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $575

JP Morgan analyst Andrea Teixeira maintains e.l.f. Beauty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) with a Overweight and lowers the price target from $207 to $167.

JP Morgan Maintains Overweight on e.l.f. Beauty, Lowers Price Target to $167

WIIM

CAPR

Capricor Therapeutics shares are trading higher after the company announced it reported long-term data from its HOPE-2 OLE study for Duchenne muscular dystrophy at the 2024 World Muscle Society Congress. Additionally, HC Wainwright & Co. raised its price target on the stock from $40 to $77.

JP Morgan analyst John Ivankoe maintains Domino's Pizza (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>) with a Neutral and lowers the price target from $470 to $450.

JP Morgan Maintains Neutral on Domino's Pizza, Lowers Price Target to $450

US Markets­­­­­­­­
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41288470/wall-street-on-backfoot-as-ppi-print-jpmorgan-earnings-loom-this-strategist-expects-positive-market">Wall Street On Backfoot As PPI Print, JPMorgan Earnings Loom: This Strategist Expects Positive Market Performance, But With Muted Returns</a></li>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41286575/s-p-pulls-back-from-record-high-as-inflation-data-dents-investor-optimism-fear-index-remains-in-gre">S&amp;P Pulls Back From Record High As Inflation Data Dents Investor Optimism: Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>
Crypto
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41288392/justin-biebers-2024-crypto-returns-discover-how-much-the-pop-icon-made-on-his-ethereum-inv">Justin Bieber&#8217;s 2024 Crypto Returns – Discover How Much The Pop Icon Made On His Ethereum Investment!</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41287244/sec-showdown-gary-gensler-defends-crypto-policy-while-commissioner-mark-uyeda-calls-it-dis">SEC Showdown: Gary Gensler Defends Crypto Policy While Commissioner Mark Uyeda Calls It &#8216;Disaster&#8217; For Assets Like Bitcoin, Ethereum, Dogecoin</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41285570/tron-founder-justin-sun-appointed-prime-minister-of-a-crypto-focused-micronation-in-europe">Tron Founder Justin Sun Appointed &#8216;Prime Minister&#8217; Of A Crypto-Focused Micronation In Europe</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41285163/tesla-themed-coins-spike-after-ev-giant-unveils-cybercab-robotaxi-why-you-should-be-carefu">Tesla-Themed Coins Spike After EV Giant Unveils &#8216;Cybercab&#8217; Robotaxi — Why You Should Be Careful</a></li>
<li><a href="https://www.benzinga.com/news/24/10/41284847/tesla-reveals-two-seater-cybercab-that-drives-itself">Tesla Unveils 2-Seater Cybercab That Drives Itself, Price Expected To Be Under $30K: Also Shows Off 20-Seater Robovan To Rival Uber Shuttle</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41284776/bitcoin-ethereum-dogecoin-muffled-after-september-inflation-dampens-rate-cut-outlook-analy">Bitcoin, Ethereum, Dogecoin Muffled After September Inflation Dampens Rate Cut Outlook: Analyst Warns Of &#8216;Downside Deviation&#8217; If King Crypto Loses This Support</a></li>
</ul>
US Politics
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41284530/trump-widens-lead-over-harris-in-betting-odds-on-prediction-markets-sets-a-new-high-on-cry">Trump Widens Lead Over Harris In Betting Odds On Prediction Markets —Sets A New High On Crypto-Based Polymarket</a></li>
<li><a href="https://www.benzinga.com/news/24/10/41284435/obama-compares-trumps-behavior-with-fidel-castro-he-has-not-stopped-whining-about-his-problems-since">Obama Compares Trump&#8217;s Behavior With Fidel Castro: He Has Not Stopped &#8216;Whining About His Problems&#8217; Since Riding Down That Golden Escalator</a></li>
<li><a href="https://www.benzinga.com/news/24/10/41284312/kamala-harris-attacks-trump-for-criticism-of-federal-response-to-hurricanes-not-a-time-for-people-to">Kamala Harris Attacks Trump For Criticism Of Federal Response To Hurricanes: &#8216;Not A Time For People To Play Politics&#8217;</a></li>
<li><a href="https://www.benzinga.com/news/24/10/41284124/trumps-return-doesnt-bother-nato-chief-stop-worrying">Trump&#8217;s Return Doesn&#8217;t Bother NATO Chief: &#8216;Stop Worrying&#8217;</a></li>
</ul>
World Politics
<ul>
<li><a href="https://www.benzinga.com/government/24/10/41289306/serbian-parliament-doesnt-pass-lithium-ban-keeps-rio-tintos-major-project-alive">Serbian Parliament Doesn&#8217;t Pass Lithium Ban, Keeps Rio Tinto&#8217;s Major Project Alive</a></li>
</ul>
US Economy
<ul>
<li><a href="https://www.benzinga.com/markets/asia/24/10/41289088/asia-and-europe-markets-mixed-crude-dips-while-gold-rises-above-2-650-global-markets-today-while-us">Asia And Europe Markets Mixed, Crude Dips While Gold Rises Above $2,650 &#8211; Global Markets Today While US Slept</a></li>
</ul>
Tech
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/10/41287736/apples-key-supplier-under-scrutiny-after-employees-detained-in-china-over-breach-of-trust-allega">Apple&#8217;s Key Supplier Under Scrutiny After Employees Detained In China Over Breach Of Trust Allegations: No Harm To iPhone Partner, Says Taiwan Council</a></li>
<li><a href="https://www.benzinga.com/news/24/10/41286584/apple-goes-from-waging-encryption-war-with-fbi-to-holding-hush-hush-global-police-summits-an-evolvin">Apple Goes From Waging Encryption War With FBI To Holding Hush-Hush Global Police Summits — An Evolving Relationship With Law Enforcement?</a></li>
<li><a href="https://www.benzinga.com/news/24/10/41286489/apple-card-slashes-savings-account-interest-for-3rd-time-following-feds-decisions-heres-what-you-nee">Apple Card Slashes Savings Account Interest For 3rd Time Following Fed&#8217;s Decisions: Here&#8217;s What You Need To Know</a></li>
<li><a href="https://www.benzinga.com/news/24/10/41285795/ios-18-users-to-benefit-from-richer-even-tickets-in-apple-wallet-after-ticketmaster-announces-suppor">iOS 18 Users To Benefit From Richer Even Tickets In Apple Wallet After Ticketmaster Announces Support</a></li>
<li><a href="https://www.benzinga.com/news/24/10/41284533/nvidias-blackwell-chip-faces-amds-mi350-challenge-in-2025-ceo-lisa-su-says-beginning-not-the-end-of">Nvidia&#8217;s Blackwell Chip Faces AMD&#8217;s MI350 Challenge In 2025: CEO Lisa Su Says, &#8216;Beginning, Not The End Of The AI Race&#8217;</a></li>
</ul>
Electric Vehicle
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/10/41289653/tesla-stock-poised-to-pullback-to-1-month-low-whats-going-on">Tesla Stock Poised To Pullback To 1-Month Low: What&#8217;s Going On?</a></li>
<li><a href="https://www.benzinga.com/markets/equities/24/10/41288999/why-uber-lyft-shares-are-speeding-up-in-fridays-premarket">Why Uber, Lyft Shares Are Speeding Up In Friday&#8217;s Premarket</a></li>
<li><a href="https://www.benzinga.com/news/24/10/41288103/elon-musks-fully-autonomous-driving-dreams-now-scheduled-for-2025-but-regulatory-hurdles-stand-in-th">Elon Musk&#8217;s Fully Autonomous Driving Dreams Now Scheduled For 2025, But Regulatory Hurdles Stand In The Way Of Tesla&#8217;s Robotaxi Rollout</a></li>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41286875/tesla-analysts-rave-over-cybercabs-design-cost-advantage-but-production-timeline-sp">Tesla Analysts Rave Over Cybercab&#8217;s Design, Cost Advantage, But Production Timeline Sparks Worry: &#8216;Too Far Out For Skeptical Investors To Get On Board&#8217;</a></li>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41286876/goldman-sachs-researchers-see-battery-prices-falling-by-nearly-50-by-2026-end-drivi">Goldman Sachs Researchers See Battery Prices Falling By Nearly 50% By 2026 End, Driving Consumer-Led EV Adoption</a></li>
<li><a href="https://www.benzinga.com/news/24/10/41286158/gm-unit-launches-home-battery-powerbank-to-rival-teslas-powerwall">GM Unit Launches Home Battery PowerBank To Rival Tesla&#8217;s Powerwall</a></li>
<li><a href="https://www.benzinga.com/news/24/10/41285255/tesla-pulls-an-apple-drops-the-charging-port-before-cupertino-could-remove-it-from-the-iphone">Tesla Pulls An Apple, Drops The Charging Port Before Cupertino Could Remove It From The iPhone</a></li>
<li><a href="https://www.benzinga.com/news/24/10/41285210/tesla-stock-falls-nearly-3-in-overnight-trading-on-robinhood-after-self-driving-cybercab-unveil">Tesla Stock Falls Nearly 3% In Overnight Trading On Robinhood After Self-Driving Cybercab Unveil</a></li>
<li><a href="https://www.benzinga.com/news/24/10/41284650/tesla-to-reveal-robotaxi-at-event-near-los-angeles-ceo-elon-musk-hints-it-could-be-a-2-seater">Tesla To Reveal Robotaxi At Event Near Los Angeles: CEO Elon Musk Hints It Could Be A 2-Seater</a></li>
</ul>
Communication
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41287462/tiktok-cuts-hundreds-of-jobs-as-company-shifts-toward-ai-based-content-moderation-report/">TikTok Cuts Hundreds Of Jobs As Company Shifts Toward AI-Based Content Moderation: Report</a></li>
</ul>
Financial
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41289783/jpmorgan-chase-q3-earnings-investment-banking-revenue-soars-29-raises-fy24-net-interest-income-outl">JPMorgan Chase Q3 Earnings: Investment Banking Revenue Soars 29%, Largest Bank Raises Net Interest Income Outlook</a></li>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41289207/wells-fargo-q3-earnings-lower-profit-on-squeezed-interest-income-but-investment-banking-fees-provid">Wells Fargo Q3 Earnings: Lower Profit On Squeezed Interest Income, But Investment Banking Fees Provides Cushion</a></li>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41288867/blackrocks-steady-climb-q3-earnings-beat-projections-assets-under-management-soars-to-11-5t">BlackRock&#8217;s Steady Climb: Q3 Earnings Beat Projections, Assets Under Management Soars To $11.5T</a></li>
<li><a href="https://www.benzinga.com/news/24/10/41287117/fidelity-data-breach-exposes-personal-information-of-over-77k-customers/">Fidelity Data Breach Exposes Personal Information Of Over 77K Customers</a></li>
<li><a href="https://www.benzinga.com/markets/equities/24/10/41284698/cathie-woods-ark-invest-dumps-over-9m-in-moderna-stock-even-with-post-covid-plans-on-the-table">Cathie Wood&#8217;s Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table</a></li>
</ul>
General
<ul>
<li><a href="https://www.benzinga.com/personal-finance/24/10/41288945/price-gouging-and-scams-on-the-rise-following-hurricanes-helene-and-milton-how-to-protect-yourse">Price Gouging And Scams On The Rise Following Hurricanes Helene And Milton &#8211; How To Protect Yourself</a></li>
</ul>
Image via Shutterstock

$BTC

$ETH

Trump Widens Lead Over Harris In Polymarket Betting Odds; Big Banks Kick Off Earnings Season - Top Headlines Today While US Slept

JP Morgan analyst Jessica Fye maintains Denali Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNLI#NASDAQ">DNLI</a>) with a Overweight and lowers the price target from $29 to $28.

DNLI

JP Morgan Maintains Overweight on Denali Therapeutics, Lowers Price Target to $28

Rodman &amp; Renshaw analyst Elemer Piros initiates coverage on Monopar Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNPR#NASDAQ">MNPR</a>) with a Buy rating and announces Price Target of $50.

Initiation

MNPR

Rodman & Renshaw Initiates Coverage On Monopar Therapeutics with Buy Rating, Announces Price Target of $50

JP Morgan analyst Bill Peterson maintains Constellium (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSTM#NYSE">CSTM</a>) with a Overweight and lowers the price target from $25 to $24.

CSTM

JP Morgan Maintains Overweight on Constellium, Lowers Price Target to $24

Piper Sandler analyst Harsh Kumar maintains Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) with a Overweight and raises the price target from $175 to $200.

Piper Sandler Maintains Overweight on Advanced Micro Devices, Raises Price Target to $200

Fangdd Network Group shares are trading higher after the company regained compliance status with the Nasdaq regarding its minimum bid price requirement.

Stellantis N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) shares are trading lower on Friday. The company disclosed that it is in the process of finding a successor for CEO Carlos Tavares, who will retire in early <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/g41282985/stellantis-leverages-its-management-organisation-with-changes-to-drive-performance-under-the-leade" rel="noreferrer noopener">2026, is already underway</a>.
This effort, led by a Special Committee of the Board chaired by John Elkann, is expected to conclude by the fourth quarter of 2025.
Apart from this, Stellantis also disclosed other management changes, effective immediately. Stellantis appointed Doug Ostermann as Chief Financial Officer, succeeding Natalie Knight, who is departing the company.
Stellantis CEO Carlos Tavares said, &#8220;During this Darwinian period for the automotive industry, our duty and ethical responsibility is to adapt and prepare ourselves for the future, better and faster than our competitors to deliver clean, safe, and affordable mobility.&#8221;
&#8221;The newly appointed leadership team members will make their valuable contributions to our overall team&#8217;s determination to tackle the challenges ahead, reinforcing and accelerating our transformation to become the preferred mobility tech company.&#8221;
The company has named Antonio Filosa&nbsp;as North America Chief Operating Officer in addition to his role as Jeep&nbsp;brand CEO, succeeding Carlos Zarlenga, whose next post will be subject to a further announcement.
The company has appointed Jean-Philippe Imparato&nbsp;as Chief Operating Officer Enlarged Europe in addition to his role as CEO of Pro One, succeeding Uwe Hochgeschurtz, who will depart the company.
Gregoire Olivier&nbsp;is appointed as Chief Operating Officer China and remains the Liaison Officer to Leapmotor.
Santo Ficili&nbsp;is appointed CEO of Maserati and Alfa Romeo and member of the Top Executive Team. Davide Grasso&#8217;s next placement will be subject to a further announcement.
In addition, the Supply Chain organization will transfer to the Manufacturing Division in an effort to improve commercial performance.
John Elkann, Chairman of the Board of Directors, said, &#8220;The Board of Directors is unanimous in its support of Carlos Tavares and for the decisive changes announced today. We are confident that these steps to simplify our organisation will strengthen our leadership team as they work to restore the Company&#8217;s performance to industry leading levels.&#8221;
Last week, Stellantis recalled 129,313 Ram 1500 vehicles in the U.S., auto safety regulator National Highway <a target="_blank" href="https://www.benzinga.com/news/24/10/41184066/stellantis-recalls-more-than-129k-ram-1500-trucks" rel="noreferrer noopener">Traffic Safety Administration (NHTSA)</a>.
Last month, Stellantis lowered the 2024 operating margin outlook to 5.5%-7%, citing North American performance issues <a target="_blank" href="https://www.benzinga.com/markets/equities/24/09/41089577/whats-going-on-with-stellantis-stock-monday" rel="noreferrer noopener">and global industry challenges</a>.
Price Action: STLA shares are down 3.65% at $12.82 at the last check on Friday.
Photo by Jonathan Weiss on Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41190669/stellantis-in-hot-water-analyst-downgrades-stock-due-to-downward-pricing-pressure-a" target="_blank" rel="noreferrer noopener">Stellantis In Hot Water: Analyst Downgrades Stock Due To Downward Pricing Pressure And Inventory Issues</a></li>
</ul>

Equities

Large Cap

Management

Movers

STLA

Chrysler Parent Stellantis Kicks Off CEO Search As Carlos Tavares Plans 2026 Retirement

In the last three months, 5 analysts have published ratings on Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>), offering a diverse range of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $286.4, a high estimate of $310.00, and a low estimate of $265.00. Witnessing a positive shift, the current average has risen by 9.56% from the previous average price target of $261.40.
<img src="https://www.benzinga.com/files/images/story/2024/1728655261_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The standing of Manhattan Associates among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Terry Tillman</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$310.00</td>
<td>$275.00</td>
</tr>
<tr>
<td>George Kurosawa</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$287.00</td>
<td>$257.00</td>
</tr>
<tr>
<td>Mark Schappel</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$285.00</td>
<td>$265.00</td>
</tr>
<tr>
<td>Mark Schappel</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$265.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Gil Luria</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$285.00</td>
<td>$260.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Manhattan Associates. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Manhattan Associates compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Manhattan Associates's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Manhattan Associates's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MANH/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Manhattan Associates analyst ratings.</a>
<h2>Delving into Manhattan Associates's Background</h2>
Manhattan Associates provides software that helps users manage their supply chains, inventory, and omnichannel operations. Customers are generally retailers, wholesalers, manufacturers, and logistics providers. The company was founded in 1990 and serves more than 1,200 customers around the world.
<h3>Unraveling the Financial Story of Manhattan Associates</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Manhattan Associates's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately 14.85%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 19.89%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Manhattan Associates's ROE stands out, surpassing industry averages. With an impressive ROE of 21.98%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Manhattan Associates's ROA stands out, surpassing industry averages. With an impressive ROA of 7.88%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.21, Manhattan Associates adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Significance of Analyst Ratings Explained</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MANH

Analyst Ratings For Manhattan Associates

10 analysts have shared their evaluations of Kenvue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVUE#NYSE">KVUE</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $23.6, a high estimate of $27.00, and a low estimate of $21.00. Marking an increase of 4.89%, the current average surpasses the previous average price target of $22.50. 
<img src="https://www.benzinga.com/files/images/story/2024/1728655251_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The analysis of recent analyst actions sheds light on the perception of Kenvue by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$25.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Keith Devas</td>
<td>Jefferies</td>
<td>Announces</td>
<td>Buy</td>
<td>$27.00</td>
<td>-</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Announces</td>
<td>Sector Perform</td>
<td>$24.00</td>
<td>-</td>
</tr>
<tr>
<td>Korinne Wolfmeyer</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$21.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$24.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Steve Powers</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$24.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$24.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$22.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Steve Powers</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Buy</td>
<td>$23.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$22.00</td>
<td>$23.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Kenvue. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Kenvue compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Kenvue's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into Kenvue's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/KVUE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Kenvue analyst ratings.</a>
<h2>Get to Know Kenvue Better</h2>
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson &amp; Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
<h3>Key Indicators: Kenvue's Financial Health</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Decline in Revenue: Over the 3 months period, Kenvue faced challenges, resulting in a decline of approximately -0.27% in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Kenvue's net margin is impressive, surpassing industry averages. With a net margin of 1.45%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 0.56%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Kenvue's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.22%, the company showcases efficient use of assets and strong financial health.
Debt Management: Kenvue's debt-to-equity ratio is below the industry average. With a ratio of 0.85, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

KVUE

Navigating 10 Analyst Ratings For Kenvue

Ratings for Advanced Energy Indus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEIS#NASDAQ">AEIS</a>) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $112.11, a high estimate of $135.00, and a low estimate of $92.00. Witnessing a positive shift, the current average has risen by 8.54% from the previous average price target of $103.29.
<img src="https://www.benzinga.com/files/images/story/2024/1728655243_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Advanced Energy Indus. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mehdi Hosseini</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$92.00</td>
<td>$103.00</td>
</tr>
<tr>
<td>Joe Quatrochi</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$98.00</td>
<td>$103.00</td>
</tr>
<tr>
<td>Robert Mason</td>
<td>Baird</td>
<td>Announces</td>
<td>Outperform</td>
<td>$128.00</td>
<td>-</td>
</tr>
<tr>
<td>Brian Chin</td>
<td>Stifel</td>
<td>Announces</td>
<td>Buy</td>
<td>$135.00</td>
<td>-</td>
</tr>
<tr>
<td>Krish Sankar</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Hold</td>
<td>$120.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Mark Miller</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$117.00</td>
<td>$117.00</td>
</tr>
<tr>
<td>Joe Quatrochi</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$103.00</td>
<td>$97.00</td>
</tr>
<tr>
<td>Mehdi Hosseini</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Neutral</td>
<td>$103.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Atif Malik</td>
<td>Citigroup</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$113.00</td>
<td>$113.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Advanced Energy Indus. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Advanced Energy Indus compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Advanced Energy Indus's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Advanced Energy Indus's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/AEIS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Advanced Energy Indus analyst ratings.</a>
<h2>Delving into Advanced Energy Indus's Background</h2>
Advanced Energy Industries Inc provides precision power-conversion measurement and control solutions that transform power into various forms for use in manufacturing and industrial equipment and applications. The firm serves original equipment manufacturers and end customers in the semiconductor, flat panel display, solar panel, and other industrial capital equipment markets. Products include thin-film power-conversion systems, which control and modify raw electrical power into a customizable, predictable power source, and power control modules, which control and measure temperature during manufacturing cycles. A majority of the firm's revenue is generated in the United States, with the rest primarily from Asia and Europe.
<h3>Advanced Energy Indus: Financial Performance Dissected</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Challenges: Advanced Energy Indus's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -12.17%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Net Margin: Advanced Energy Indus's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.12% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 1.3%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.59%, the company showcases effective utilization of assets.
Debt Management: Advanced Energy Indus's debt-to-equity ratio surpasses industry norms, standing at 0.88. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Analyst Ratings: Simplified</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEIS

Analyst Ratings For Advanced Energy Indus

Macro Economic Events

Econ #s

Economics

Michigan Consumer Sentiment For October 68.9 Vs 70.9 Est.; 70.1 Prior

Throughout the last three months, 16 analysts have evaluated Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>), offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Colgate-Palmolive, presenting an average target of $106.81, a high estimate of $122.00, and a low estimate of $91.00. This upward trend is apparent, with the current average reflecting a 4.56% increase from the previous average price target of $102.15.
<img src="https://www.benzinga.com/files/images/story/2024/1728655233_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Colgate-Palmolive. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$114.00</td>
<td>$113.00</td>
</tr>
<tr>
<td>Korinne Wolfmeyer</td>
<td>Piper Sandler</td>
<td>Announces</td>
<td>Overweight</td>
<td>$121.00</td>
<td>-</td>
</tr>
<tr>
<td>Chris Carey</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Underweight</td>
<td>$100.00</td>
<td>-</td>
</tr>
<tr>
<td>Steve Powers</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$109.00</td>
<td>$107.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$122.00</td>
<td>$119.00</td>
</tr>
<tr>
<td>Robert Moskow</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$115.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Callum Elliott</td>
<td>Bernstein</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$103.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Steve Powers</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$107.00</td>
<td>$104.00</td>
</tr>
<tr>
<td>Dara Mohsenian</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$111.00</td>
<td>$103.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$96.00</td>
<td>$91.00</td>
</tr>
<tr>
<td>Kaumil Gajrawala</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$95.00</td>
<td>$103.00</td>
</tr>
<tr>
<td>Robert Moskow</td>
<td>TD Cowen</td>
<td>Announces</td>
<td>Buy</td>
<td>$110.00</td>
<td>-</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$105.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$91.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Robert Ottenstein</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$106.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Steve Powers</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$104.00</td>
<td>$98.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Colgate-Palmolive. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Colgate-Palmolive compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Colgate-Palmolive's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into Colgate-Palmolive's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CL/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Colgate-Palmolive analyst ratings.</a>
<h2>Delving into Colgate-Palmolive's Background</h2>
Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which primarily sells its products through veterinarians and specialty pet retailers.
<h3>Colgate-Palmolive's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Growth: Colgate-Palmolive's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 4.89%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Staples sector.
Net Margin: Colgate-Palmolive's net margin is impressive, surpassing industry averages. With a net margin of 14.45%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 414.16%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Colgate-Palmolive's ROA stands out, surpassing industry averages. With an impressive ROA of 4.42%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Colgate-Palmolive's debt-to-equity ratio stands notably higher than the industry average, reaching 70.54. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>Analyst Ratings: Simplified</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On Colgate-Palmolive Through 16 Analysts

In the preceding three months, 7 analysts have released ratings for Energizer Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENR#NYSE">ENR</a>), presenting a wide array of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $34.14, a high estimate of $40.00, and a low estimate of $28.00. Surpassing the previous average price target of $32.43, the current average has increased by 5.27%.
<img src="https://www.benzinga.com/files/images/story/2024/1728655224_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A comprehensive examination of how financial experts perceive Energizer Hldgs is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$32.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Bill Chappell</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$40.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$29.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$38.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Robert Ottenstein</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$40.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$28.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$32.00</td>
<td>$31.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Energizer Hldgs. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Energizer Hldgs compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Energizer Hldgs's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Energizer Hldgs's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/ENR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Energizer Hldgs analyst ratings.</a>
<h2>About Energizer Hldgs</h2>
Energizer Holdings Inc makes and distributes household batteries, specialty batteries, and lighting products. Energizer offers batteries using lithium, alkaline, carbon-zinc, nickel-metal hydride, zinc-air, and silver oxide technologies. These products are sold under the Energizer, Rayovac, Varta and Eveready brands at performance and premium price segments. It also offers auto care products in the appearance, fragrance, performance, and air conditioning recharge product categories. The company operates in two geographical segments: Americas and International, of which the majority of its revenue is derived from the Americas segment.
<h3>Energizer Hldgs's Economic Impact: An Analysis</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Energizer Hldgs displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 0.29%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Energizer Hldgs's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -6.24%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Energizer Hldgs's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -27.84%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Energizer Hldgs's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -1.03%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Energizer Hldgs's debt-to-equity ratio surpasses industry norms, standing at 26.9. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Evaluating Energizer Hldgs: Insights From 7 Financial Analysts

Looking into the current session, FirstEnergy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FE#NYSE">FE</a>) shares are trading at $42.27, after a 0.14% drop. Over the past month, the stock decreased by 4.52%, but over the past year, it actually increased by 17.42%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2024/1728655216_0_0.png" alt="Past Year Chart" />

<h3>Comparing FirstEnergy P/E Against Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
FirstEnergy has a better P/E ratio of 27.13 than the aggregate P/E ratio of 18.77 of the Electric Utilities industry. Ideally, one might believe that FirstEnergy Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1728655217_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

AddLife

AddLife (ADDLF) Forecast

AddLife (OTC:ADDLF) Stock, Quote.Headers.trade-ideas